NeuroOne Medical Technologies Corporation - Common Stock (NMTC)

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Veteran Med-Tech Research Analyst & Public Company Executive to Bring Strategic Experience, Industry Relationships and Vision to the Board

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System with First Two Facial Pain Patients Successfully Treated

EDEN PRAIRIE, MINN. - December 11, 2025 ( NEWMEDIAWIRE ) - NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal fourth quarter and year ended September 30, 2025, before market open on December 17, 2025.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Further Validates NeuroOne’s Patented Platform Technology for Both Brain Ablation and Pain Management Procedures

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

EDEN PRAIRIE, MINN. - November 19, 2025 ( NEWMEDIAWIRE ) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its participation in the following medical industry conferences:

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

EDEN PRAIRIE, MINN. - November 5, 2025 ( NEWMEDIAWIRE ) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying NeuroOne that it has been granted a 180-day extension, until May 4, 2026, to regain compliance with the requirement for the Company’s common stock, to maintain a minimum bid price of $1.00 per share for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2).

EDEN PRAIRIE, MINN. - October 16, 2025 ( NEWMEDIAWIRE ) - NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the promotion of Emily Johns to the expanded role of Chief Administrative Officer (CAO) and General Counsel. Johns, who joined NeuroOne earlier this year as its General Counsel, will continue to lead the legal strategy for NeuroOne. Additionally, she will now oversee all human resources, compliance, security and risk areas of the organization.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Growing IP Portfolio Signals Further Opportunity for Expansion of Company’s Technology Platform

EDEN PRAIRIE, MINN. - October 6, 2025 ( NEWMEDIAWIRE ) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced preliminary unaudited product revenue for the fiscal year ended September 30, 2025.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

EDEN PRAIRIE, MINN. - September 29, 2025 ( NEWMEDIAWIRE ) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that it will hold a virtual roadshow webinar to discuss its business operations, recent FDA clearance and corporate updates.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Investor Summit Group, committed to advancing the MicroCap and SmallCap investment community, announces that the November 21, 2024 Winter Investor Summit Virtual Conference presentations are now available for on-demand viewing.

EDEN PRAIRIE, MN / ACCESSWIRE / November 13, 2024 / NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.

NeuroOne Medical Technologies (NASDAQ: NMTC) is committed to improving surgical care options and outcomes for patients suffering from neurological disorders including epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries. The company’s minimally invasive and high-definition/high-precision solutions offer combination diagnostic and therapeutic functions for EEG recording, tissue ablation, as well as potentially for deep brain stimulation. Along with three FDA-cleared product families, Evo(R) Cortical Electrodes, Evo(R) sEEG Electrodes, and the OneRF(R) Ablation System, the company is engaged in R&D for drug delivery and spinal cord stimulation programs and is exploring potential applications of its medical technology using artificial intelligence. For more information, visit the company’s website at www.nmtc1.com .

EDEN PRAIRIE, MN / ACCESSWIRE / April 6, 2023 / As medical technology progresses, the world's approach to surgical operations is also advancing and changing significantly. As part of this, minimally invasive surgery (MIS), in recent years, has taken the forefront of the surgical industry, and there are no surprises why.

Palm Beach, FL – December 14, 2022 – FinancialNewsMedia.com News Commentary – A cardiac arrhythmia is an irregular heartbeat caused by incorrect electrical signals that govern the beats of the heart. The improper signaling pathway causes the heart to beat too rapidly, which is tachycardia, or too gradually, which is bradycardia, or inconsistently. To avoid […]